Acute Pain Management with Ketorolac and Steroids

Introduction to Acute Pain Management

The American Academy of Family Physicians recommends ketorolac for short-term management of moderately severe acute pain requiring opioid-level analgesia 1
The American Academy of Family Physicians suggests that ketorolac provides effective analgesia comparable to opioids for moderate to severe pain in emergency settings 1
The American Academy of Family Physicians states that intramuscular ketorolac (60 mg) can be administered every 15-30 minutes with a maximum daily dosage of 120 mg, and treatment should not exceed 5 days 1

The American Academy of Family Physicians indicates that ketorolac is effective for various acute pain conditions, including renal colic, migraine headache, musculoskeletal pain, and postoperative pain, although the evidence is not fully cited here 1

The American Academy of Family Physicians recommends that systemic steroids are not widely used for routine acute pain management 1, 2
The American Academy of Family Physicians suggests that there is insufficient evidence supporting the use of steroids for acute migraine attacks 1, 2
The American College of Rheumatology recommends that steroid therapy may be considered for status migrainosus (severe, continuous migraine lasting up to one week), but evidence for efficacy is limited 1
The American College of Rheumatology suggests that for acute gout attacks in NPO patients, intravenous or intramuscular methylprednisolone (0.5-2.0 mg/kg) may be appropriate when other treatments cannot be used 3

The Centers for Disease Control and Prevention recommends that NSAIDs (oral) are first-line for mild to moderate pain and have fewer side effects than parenteral options 4
The Centers for Disease Control and Prevention suggests that acetaminophen combined with NSAIDs provides effective analgesia for many acute pain conditions 4
The American Headache Society recommends that for migraine, triptans, NSAIDs, antiemetics, and combination therapies are recommended before considering opioids or steroids 4
The American Society of Anesthesiologists recommends that combining non-pharmacologic methods with appropriate medications provides optimal pain relief 4
The American College of Rheumatology suggests that topical ice application is an appropriate adjunctive measure for acute pain conditions including gout 3
The European Society of Anaesthesiology recommends that for postoperative pain, local anesthetic techniques (wound infiltration, nerve blocks) can reduce the need for systemic analgesics 5

The American Academy of Family Physicians recommends assessing pain severity and type, and beginning with oral NSAIDs and/or acetaminophen for mild to moderate pain 4, 6
The American Academy of Family Physicians suggests considering IM ketorolac for moderate to severe pain requiring parenteral therapy 1
The American College of Rheumatology recommends considering IM steroids only for specific conditions like status migrainosus or acute gout in NPO patients 1, 3

The American Society of Anesthesiologists recommends ketorolac as part of multimodal analgesia to reduce overall opioid requirements, providing opioid-level analgesia without respiratory depression, sedation, or dependence issues associated with opioids 7
Ketorolac may reduce postoperative nausea, vomiting, and sedation compared to opioid-based regimens, with studies showing comparable efficacy to morphine and meperidine for moderate to severe pain 8

The risk of acute kidney injury is particularly high in patients with marginal kidney function when using ketorolac, highlighting the need for caution in patients with renal impairment 8

In pediatric patients, ketorolac can be used at doses of 0.5-1 mg/kg, and is particularly effective in reducing postoperative opioid requirements, according to the American Academy of Pediatrics 8

Opioids produce addiction by triggering dopamine release in the nucleus accumbens, creating pleasurable effects and learned associations that drive drug-seeking behavior, which is not the case with ketorolac 9, 10
The American College of Medicine suggests that ketorolac provides opioid-level analgesia without respiratory depression, sedation, euphoria, or any dependence issues, as it works by reversibly inhibiting cyclooxygenase enzymes to reduce pain and inflammation 9, 10

The American Academy of Pain Medicine recommends that when combined with opioids, ketorolac reduces opioid requirements by 25-50%, which decreases opioid-related adverse events including respiratory depression, nausea, vomiting, and ileus, with an opioid-sparing effect that is particularly valuable given that opioid addiction develops in less than 8% of patients prescribed opioids for pain 9, 10
Patients with a history of substance abuse can safely receive ketorolac without triggering relapse or developing new substance use disorders, as NSAIDs lack abuse potential, according to the American Society of Addiction Medicine 9, 11

Unlike opioids, which cause physical dependence with withdrawal symptoms upon discontinuation, ketorolac can be stopped abruptly without any withdrawal syndrome, as stated by the National Institute on Drug Abuse 12, 11